A Frequently Asked Questions (FAQs) on SARS-CoV-2 variant Omicron, released by the Ministry of Health and Family Welfare, on November 3 says that “given the fast pace of vaccination in India and high exposure to delta variant as evidenced by high seropositivity, the severity of the disease is anticipated to be low. However, scientific evidence is still evolving.”